Sponsor or institution
Clinical trials and research at Retham Technologies, INC.
As of November 12, 2026, Find a Trial lists 4 NIH-funded research projects at this institution, with $4.1 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4NIH research projects
NIH-funded research (4)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
A faster, more accurate test for HIT antibodies
A new in vitro diagnostic test aims to quickly and accurately detect harmful antibodies linked to heparin-induced thrombocytopenia in patients who need help deciding on treatment.
-
Developing a test to detect harmful antibodies related to Heparin-induced Thrombocytopenia
This study is working on a new, more accurate test to help doctors find out if patients have Heparin-induced Thrombocytopenia (HIT), a serious condition that can happen when they receive heparin treatment, so that patients can get the right care without the confusion of false-positive results from current tests.
-
A New Test for Heparin-Induced Thrombocytopenia (HIT)
This project is developing a more accurate and faster blood test to identify patients who have a serious reaction to heparin, called Heparin-induced Thrombocytopenia (HIT).
-
Developing a test to detect harmful antibodies related to Heparin-induced Thrombocytopenia
This study is working on a new, more accurate test to help doctors find out if patients have Heparin-induced Thrombocytopenia (HIT), a serious condition that can happen when they receive heparin treatment, so that patients can get the right care and feel better faster.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.